Overview
To kick off the new year, and as a prelude to DIA’s Advertising and Promotion Regulatory Affairs Conference, join us to learn about the most recent developments in the landscape of FDA advertising and promotion and how they impact your company’s marketing and communications plans. During this webinar, we will begin with a brief year in review of the latest regulatory activities in this space, followed by a deeper dive into emerging regulations and policies for DTC communications. Key topics include FDA’s recent draft guidance on quantitative information, disclosure of risk information, and FDA’s proposed framework for “prescription drug-use-related” software.
Have an account?